MedWatch

Ambu plagued by transportation troubles in disappointing year – CEO has a card up his sleeve

Two downgrades with a prospect of increased costs on freights and raw materials do not evoke optimism with Ambu's CEO Juan Jose Gonzalez when it comes to next year's financial guidance. The added expenses will impact Ambu's revenue, but the CEO still have moves ...

Photo: Ambu / PR

Ambu has been left with a bill of DKK 70m (USD 10.9m) for increased transportation costs over the past year, and with two downgrades during this period, CEO Juan Jose Gonzalez would prefer to avoid a similar situation for the new financial year.

That's why he has attempted to get ahead of the uncertain conditions on the global shipping market with explosive freight rates, higher expenses as the medtech company's most important products are transported by air and spiking raw material prices. The result is 2021/2022 financial guidance.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs